Lin Bioscience Stock

Lin Bioscience Liabilities

The The Liabilities of Lin Bioscience (6696.TWO) as of Sep 5, 2026 is 291.24 M TWD. In the previous year, The Liabilities was 173.22 M TWD — a change of 68.14% (higher).

Liabilities

291.24 MTWD

YoY

68.14%

Last updated:

In 2026, Lin Bioscience's total liabilities amounted to 291.24 M TWD, a 68.14% difference from the 173.22 M TWD total liabilities in the previous year.

The Lin Bioscience Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Liabilities
Date
Liabilities
Jan 1, 2018
17.85 M TWD
Jan 1, 2019
105.97 M TWD
Jan 1, 2020
308.87 M TWD
Jan 1, 2021
470.25 M TWD
Jan 1, 2022
116.06 M TWD
Jan 1, 2023
167.73 M TWD
Jan 1, 2024
173.22 M TWD
Jan 1, 2025
291.24 M TWD
The Lin Bioscience Liabilities history
YEARLiabilitiesYoY
291.24 MTWD+68.14%
173.22 MTWD+3.27%
167.73 MTWD+44.53%
116.06 MTWD-75.32%
470.25 MTWD+52.25%
308.87 MTWD+191.48%
105.97 MTWD+493.65%
17.85 MTWD-29.32%
25.25 MTWD-48.47%
49.01 MTWD—
Access this data via the Eulerpool API
Get Free API Key

Lin Bioscience Stock analysis

What does Lin Bioscience do? Lin Bioscience is one of the most popular companies on Eulerpool.

Liabilities Details

Assessing Lin Bioscience's Liabilities

Lin Bioscience's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Lin Bioscience's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Lin Bioscience's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Lin Bioscience's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Lin Bioscience’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Lin Bioscience stock

The Liabilities of Lin Bioscience is 291.24 M TWD in 2026.

The Liabilities of Lin Bioscience changed from 173.22 M TWD to 291.24 M TWD, representing a 68.14% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Liabilities Lin Bioscience since 2006 – with annual values, charts, and detailed analysis.

The Liabilities's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Liabilities's Lin Bioscience historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — Lin Bioscience

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Lin Bioscience